Form 8-K PENTAIR plc For: Jul 31
Tweet
Share
E-mail
http://archive.fast-edgar.com/20140731/ANZZT222Z229K242222K22Z2BPHOZZ272262
Filed on: July 31, 2014
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Innovent Biologics Announces First Patient Dosed in a Phase 3 Clinical Trial of IBI3003(GPRC5D/BCMA/CD3 Tri-specific Antibody) for the Treatment of Multiple Myeloma
- MoonLake Announces Week 52 Results of Sonelokimab from its Phase 3 VELA Program in Hidradenitis Suppurativa and Confirms Investor Day on June 22, 2026
- Acorn Acquires B Online Learning to Close the Gap Between Learning Investment and Workforce Readiness
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
